Infection of common marmosets with hepatitis C virus/GB virus-B chimeras

Hepatology

Volumn 59, Issue 3, 2014, Pages 789-802

  Li, Tingting ^a   Zhu, Shaomei ^a   Shuai, Lifang ^b   Xu, Yuxia ^a   Yin, Sen ^a   Bian, Yixin ^a   Wang, Yuanzhan ^c   Zuo, Bingfeng ^d   Wang, Wenjing ^a   Zhao, Shuoxian ^a   Zhang, Ling ^a   Zhang, Jingang ^e   Gao, George F ^f   Allain, Jean Pierre ^a,g   Li, Chengyao ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangzhou Military Centre of Disease Control   (China)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^f INSTITUTE OF MICROBIOLOGY   (China)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; ENVELOPE PROTEIN; STRUCTURAL PROTEIN; TACROLIMUS; VIRUS PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CALLITHRIX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; STRUCTURAL GENE; T LYMPHOCYTE; TREATMENT DURATION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS GENE; VIRUS GENOME; VIRUS HEPATITIS; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

ANIMALS; CALLITHRIX; CELLS, CULTURED; CHIMERA; DISEASE MODELS, ANIMAL; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE;

EID: 84896717818     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26750     Document Type: Article

References (34)

1. Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992;258:135-140.
2. Farci P, London WT, Wong DC, Dawson GJ, Vallari DS, Engle R, et al. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis 1992;165:1006-1011.
3. Abe K, Kurata T, Teramoto Y, Shiga J, Shikata T. Lack of susceptibility of various primates and woodchucks to hepatitis C virus. J Med Primatol 1993;22:433-434.
4. Tabor E, Seeff LB, Gerety RJ. Lack of susceptibility of marmosets to human non-A, non-B hepatitis. J Infect Dis 1979;140:794-797.
5. Jeremy AG, Kevin W, Paul W, Andrew JM. Lack of susceptibility of the cottontop tamarin to hepatitis C infection. J Med Virol 1997;52:286-288.
6. Bukh J, Apgar CL, Yanagi M. Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 1999;262:470-478.
7. Sbardellati A, Scarselli E, Verschoor E, De Tomassi A, Lazzaro D, Traboni C. Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J Gen Virol 2001;82:2437-2448.
8. Jacob JR, Lin KC, Tennant BC, Mansfield KG. GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. J Gen Virol 2004;85:2525-2533.
9. Bright H, Carroll AR, Watts PA, Fenton RJ. Development of a GB virus B marmoset model and its validation with a novel series of Hepatitis C Virus NS3 protease inhibitors. J Virol 2004;78:2062-2071.
10. Rijnbrand R, Yang Y, Beales L, Bodola F, Goettge K, Cohen L, et al. A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins. Hepatology 2005;41:986-994.
11. Takikawa S, Engle RE, Emerson SU, Purcell RH, St Claire M, Bukh J. Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein. Proc Natl Acad Sci U S A 2006;103:3345-3350.
12. Haqshenas G, Dong X, Netter H, Torresi J, Gowans EJ. A chimeric GB virus B encoding the hepatitis C virus hypervariable region 1 is infectious in vivo. J Gen Virol 2007;88:895-902.
13. Griffin S, Trowbridge R, Thommes P, Parry N, Rowlands D, Harris M, et al. Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo. J Hepatol 2008;49:908-915.
14. Li T, Chen Z, Zeng J, Zhang J, Wang W, Zhang L, et al. Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun 2011;415:503-508.
15. Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, et al. Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol 2011;49:1730-1737.
16. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
17. INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. J Transl Med 2009;7:25.
18. McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT, et al. Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 2009;49:1051-1060.
19. Woollard DJ, Haqshenas G, Dong X, Pratt BF, Kent SJ, Gowans EJ. Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets. J Virol 2008;82:3054-3060.
20. Martin A, Bodola F, Sangar DV, Goettge K, Popov V, Rijnbrand R, et al. Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci U S A 2003;100:9962-9967.
21. Takikawa S, Engle RE, Faulk KN, Emerson SU, Purcell RH, Bukh J. Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins. J Gen Virol 2010;91:727-733.
22. Lanford RE, Chaveza D, Notvall L, Brasky KM. Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 2003;311:172-180.
23. Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991;325:98-104.
24. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000;6:578-582.
25. Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, et al. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet 2005;365:327-329.
26. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, Streeck H, et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 2012;209:61-75.
27. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999;10:439-449.
28. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003;302:659-662.
29. Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA, et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003;197:1645-1655.
30. Barth H, Rybczynska J, Patient R, Choi Y, Sapp RK, Baumert TF, et al. Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees. Hepatology 2011;54:1135-1148.
31. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798-801.
32. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998;30:938-941.
33. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wölk B, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007;446:801-805.
34. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009;457:882-886.